PEN - Penumbra Inc


299.78
1.530   0.510%

Share volume: 609,106
Last Updated: 04-25-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%

$298.25
1.53
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
15%
Profitability 3%
Dept financing 10%
Liquidity 53%
Performance 20%
Company vs Stock growth
vs
Performance
5 Days
8.14%
1 Month
11.19%
3 Months
9.92%
6 Months
43.61%
1 Year
48.38%
2 Year
5.87%
Key data
Stock price
$299.78
P/E Ratio 
243.87
DAY RANGE
$292.94 - $305.74
EPS 
$1.31
52 WEEK RANGE
$148.00 - $310.00
52 WEEK CHANGE
$48.38
MARKET CAP 
10.300 B
YIELD 
N/A
SHARES OUTSTANDING 
38.726 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-23-2025
BETA 
0.38
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$762,642
AVERAGE 30 VOLUME 
$541,768
Company detail
CEO: Adam Elsesser
Region: US
Website: penumbrainc.com
Employees: 3,900
IPO year: 2015
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand.

Recent news
loading